Sanders Capital’s Sanofi SNY Stock Holding History

Sanders Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-76,497	Closed	-$2.92M	–	44
2016 Q3	$2.92M	Sell	76,497 -1,800	-2%	-$72.2K	0.02%	43
2016 Q2	$3.28M	Buy	78,297 +2,997	+4%	+$123K	0.03%	44
2016 Q1	$3.02M	Hold	75,300	–	–	0.03%	45
2015 Q4	$3.21M	Hold	75,300	–	–	0.03%	44
2015 Q3	$3.57M	Sell	75,300 -3,400	-4%	-$173K	0.04%	44
2015 Q2	$3.9M	Sell	78,700 -2,200	-3%	-$111K	0.04%	44
2015 Q1	$4M	Sell	80,900 -1,500	-2%	-$71.7K	0.04%	43
2014 Q4	$3.76M	Buy	82,400 +6,600	+9%	+$320K	0.04%	45
2014 Q3	$4.28M	Hold	75,800	–	–	0.05%	44
2014 Q2	$4.03M	Hold	75,800	–	–	0.04%	46
2014 Q1	$3.96M	Buy	75,800 +9,600	+15%	+$486K	0.05%	47
2013 Q4	$3.55M	Buy	66,200 +11,900	+22%	+$614K	0.04%	48
2013 Q3	$2.75M	Buy	54,300 +1,100	+2%	+$56K	0.04%	47
2013 Q2	$2.74M	Buy	+53,200	New	+$2.83M	0.04%	46

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Sanders Capital's SNY Position: Q4 2016 in Review

Sanders Capital sold out of Sanofi (SNY) in Q4 2016, closing a stake of 76,497 shares — an estimated $2.92M sold.

Sanders Capital first reported a position in SNY in Q2 2013 and held it in 14 quarters. The position peaked at $4.28M in Q3 2014. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2016.

Sanders Capital reported no remaining Sanofi position as of Q4 2016 after selling out during the quarter.
Sanders Capital sold 76,497 Sanofi shares in Q4 2016, an estimated $2.92M.
Sanders Capital first reported a position in Sanofi in Q2 2013 and held it in 14 quarters.
Sanders Capital's Sanofi position peaked at $4.28M in Q3 2014.
476 funds tracked by Wall St. Rank held Sanofi as of Q4 2016.

Based on Sanders Capital's 13F filing for Q4 2016, filed 1 Feb 2017.